| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 04/17/2003 | CA2463339A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 04/17/2003 | CA2463198A1 Pyrrolidinone derivatives |
| 04/17/2003 | CA2462950A1 3-[4-(substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2-indolinone derivatives as kinase inhibitors |
| 04/17/2003 | CA2462881A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process |
| 04/17/2003 | CA2462862A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists |
| 04/17/2003 | CA2462301A1 Para-amino benzoic acids as integrin antagonists |
| 04/17/2003 | CA2461435A1 Angiopoietin-2 specific binding agents |
| 04/17/2003 | CA2461064A1 Inhibition of stat-1 |
| 04/17/2003 | CA2460476A1 Protein modification and maintenance molecules |
| 04/17/2003 | CA2458464A1 Monoclonal and cdr-grafted antibodies specific for human kdr |
| 04/16/2003 | EP1302206A1 Methods and means for the use of the adventitial toll-like receptor |
| 04/16/2003 | EP1302201A1 Pharmaceutical composition improved in peroral absorbability |
| 04/16/2003 | EP1301598A2 Cell cycle proteins and mitosis-associated molecules |
| 04/16/2003 | EP1301595A2 G-protein coupled receptors |
| 04/16/2003 | EP1301539A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 04/16/2003 | EP1301535A2 G-protein coupled receptors |
| 04/16/2003 | EP1301524A1 B7-like polynucleotides, polypeptides, and antibodies |
| 04/16/2003 | EP1301522A1 Novel compounds and methods |
| 04/16/2003 | EP1301516A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 04/16/2003 | EP1301507A2 Mannich base prodrugs of 3 - (pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases |
| 04/16/2003 | EP1301497A1 Colchinol derivatives as vascular damaging agents |
| 04/16/2003 | EP1301495A2 Inhibitors of copper-containing amine oxidases |
| 04/16/2003 | EP1301490A2 5-substituted 2-aryl-4-pyrimidinones |
| 04/16/2003 | EP1301488A1 Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists |
| 04/16/2003 | EP1301484A2 Capsaicin receptor ligands |
| 04/16/2003 | EP1301472A2 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 04/16/2003 | EP1301207A2 Compositions for treating bacterial infections, containing an oxazolidinone compound, sulbactam and and ampicillin |
| 04/16/2003 | EP1301200A2 Peptide pharmaceutical formulations |
| 04/16/2003 | EP1301196A2 Stimulation of bone growth with thrombin peptide derivatives |
| 04/16/2003 | EP1301193A1 Process for preparing composition comprising medicinal herb extract for preventing and curing arthritis and composition thereof |
| 04/16/2003 | EP1301192A1 Use of polysulphated cyclodextrins for treating osteoarthritis |
| 04/16/2003 | EP1301189A2 USE OF 2-METHYLENE-19-NOR-20(S)-1$g(a),25-DIHYDROXYVITAMIN D 3? TO INCREASE BONE STRENGTH |
| 04/16/2003 | EP1181017B1 Metalloprotease inhibitors |
| 04/16/2003 | EP1121100B1 Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin |
| 04/16/2003 | EP1090027B1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same |
| 04/16/2003 | EP1007505B1 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives |
| 04/16/2003 | EP0869945B1 Catechol diethers derivatives useful as pharmaceutical agents |
| 04/16/2003 | CN1411461A Thienopyridine derivatives and their preparing process and use |
| 04/16/2003 | CN1411458A Saccharin derivatives as orally active elastase inhibitors |
| 04/16/2003 | CN1411456A Chemokine receptor binding heterocyclic compounds |
| 04/16/2003 | CN1411449A N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses |
| 04/16/2003 | CN1411447A Polymorphic crystalline forms of celecoxib |
| 04/16/2003 | CN1411446A Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
| 04/16/2003 | CN1411444A Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 04/16/2003 | CN1411435A Novel use of phenyl hetero alkylamine derivatives |
| 04/16/2003 | CN1411386A Treatment of subnormal bone mineral density |
| 04/16/2003 | CN1411373A Novel processes for making-and new crystalline form of-leflunomide |
| 04/16/2003 | CN1410113A Plaster for treating femur necrosis due to deficiency of blood and its preparation method |
| 04/16/2003 | CN1410112A Fuyuan plaster for promoting blood circulation |
| 04/16/2003 | CN1410094A Ointment for treating nuchal rigidity |
| 04/16/2003 | CN1410087A Pain eliminating liquor No.1 |
| 04/16/2003 | CN1410082A Bone strengthening pill and its preparation method |
| 04/16/2003 | CN1410081A Capsule for treating rheumatism, rheumatoid archritis |
| 04/16/2003 | CN1410054A II type collagen water soluble dispersion composition, its preparation method and application |
| 04/16/2003 | CN1105726C Human calcitonin analogue |
| 04/16/2003 | CN1105723C Spirocyclic metalloprotease inhibitors |
| 04/16/2003 | CN1105577C Parathyroid hormone and raloxifene for increasing bone mass |
| 04/16/2003 | CN1105574C Therapeutic uses of bactericidal/permeability increasing protein products |
| 04/16/2003 | CN1105571C Hyperostereogeny treating medicine and its preparing process |
| 04/16/2003 | CN1105570C Medicinal composition for curing arthritis and osteoarth ropathy and its preparing method |
| 04/16/2003 | CN1105564C Medicine for warming kidney and treating wind-dampness syndrome and preparation process thereof |
| 04/15/2003 | US6548715 Which lacks the combined presence of the trans-fused ring; increased therapeutic potential; for cell proliferation; veterinary medicine |
| 04/15/2003 | US6548699 4,4*-(Isopropylidenedithio)-(2*,6*-di-tert-butylphenol)-(2,6-d i-tert-butylphenol-O*-acetic acid); antiarthritic, antiinflammatory agents; rheumatic and cardiovascular disorders |
| 04/15/2003 | US6548668 Stabilizer for proteins |
| 04/15/2003 | US6548667 For prevention and treatment of diseases caused by overexpression and overactivation of matrix metalloproteinase |
| 04/15/2003 | US6548638 Peptoid and nonpeptoid containing α-keto oxadiazoles as serine protease inhibitors |
| 04/15/2003 | US6548529 Heterocyclic containing biphenyl aP2 inhibitors and method |
| 04/15/2003 | US6548522 N-substituted 2,2-diphenylacetamide or N-substituted 2-phenyl-2-pyridinylacetamide |
| 04/15/2003 | US6548520 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 04/15/2003 | US6548514 Inhibitors of p38 kinase/cytokine suppressive binding protein (CSBP)/reactivating kinase (RK); 1-((pyridyl)aminocarbonyl)-3-((hetero)arylaminocarbonyl)benzene derivatives; treating cytokine related diseases and disorders |
| 04/15/2003 | US6548513 (E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(methyl(methyl -sulfonyl)amino)pyrimidin-5-yl)-(3R,5S)-3,5-dihydroxyhept-6-enoic acid or salt, stabilized by an inorganic salt having a multivalent cation, excluding synthetic hydrotalcite |
| 04/15/2003 | US6548503 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| 04/15/2003 | US6548500 Treating a cell adhesion-mediated diseases such as multiple sclerosis, asthma, atherosclerosis, rheumatoid arthritis, meningitis, comprising administering to a warm blooded animal a nitrogen atoms containing bicyclic compound |
| 04/15/2003 | US6548483 Nutritional preparation comprising ribose and medical use thereof |
| 04/15/2003 | US6548482 Treatment of osteoporosis |
| 04/15/2003 | US6548279 For polypeptides able to catalyze the enzymatic function of superoxide dismutase, carbonic anhydrase, or HIV protease |
| 04/15/2003 | US6548270 An expression vector comprising a recombinant polynucleotide encoding a protein containing specific amino acid sequence; genetic engineering |
| 04/10/2003 | WO2003029819A1 Method of screening preventive/remedy for bone/joint diseases |
| 04/10/2003 | WO2003029437A2 Secreted proteins |
| 04/10/2003 | WO2003029424A2 Novel proteins and nucleic acids encoding same |
| 04/10/2003 | WO2003029420A2 Apo-2 ligand variants and uses thereof |
| 04/10/2003 | WO2003029413A2 A novel g protein-coupled receptor, gave 10 |
| 04/10/2003 | WO2003029410A2 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER |
| 04/10/2003 | WO2003029293A2 Modulators of notch ic protease activity for use in immunotherapy |
| 04/10/2003 | WO2003029283A2 Genetic sequences related to bone diseases in the osteopetrotic grey-lethal (gl) mouse |
| 04/10/2003 | WO2003029268A1 Androstane 17-beta-carboxamides as androgen receptor modulators |
| 04/10/2003 | WO2003029245A1 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 04/10/2003 | WO2003029242A1 NF-λB INHIBITORS |
| 04/10/2003 | WO2003029212A1 Indole derivatives as cox ii inhibitors |
| 04/10/2003 | WO2003029200A2 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/10/2003 | WO2003029199A1 Benzene derivatives, process for preparing the same and use thereof |
| 04/10/2003 | WO2003029187A1 Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them |
| 04/10/2003 | WO2003029185A1 Novel compounds |
| 04/10/2003 | WO2003028781A1 Glycosaminoglycan-polycation complex crosslinked by polyfunctional crosslinking agent and process for producing the same |
| 04/10/2003 | WO2003028764A1 Therapeutically useful triethyleneglycol cholesteryl oligonucleotides |
| 04/10/2003 | WO2003028749A1 Matrix metalloprotease inhibitor |
| 04/10/2003 | WO2003028741A1 Composition of hypochlorous acid and its applications |
| 04/10/2003 | WO2003028726A1 Quinoline derivatives as neuropeptide y antagonists |
| 04/10/2003 | WO2003028720A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 04/10/2003 | WO2003028715A2 Methods using 1, 2-dithiol-3-thiones and their derivatives and metabolites for inhibiting angiogenesis |